Literature DB >> 12751000

Familial mediterranean fever: revisiting an ancient disease.

Seza Ozen1.   

Abstract

UNLABELLED: Familial Mediterranean fever (FMF) is an auto-inflammatory disease characterised by periodic attacks of fever and serositis. Recent genetic and epidemiological research have highlighted the importance of this disease. FMF is the most frequent periodic fever syndrome and is transmitted in an autosomal recessive fashion. The disease is caused by mutations in the gene on the short arm of chromosome 16, coding for the protein "pyrin". Pyrin is mainly expressed in neutrophils and monocytes and is among the proteins involved in the interleukin-1 inflammatory pathway. The recurrent attacks of fever are accompanied by severe abdominal pain, arthritis and/or chest pain along with a marked increase in acute phase reactants. Among these, serum amyloid A protein is especially important since it is the precursor of the amyloid A fibrils deposited in secondary renal amyloidosis. Renal amyloidosis has a grave prognosis. Differential diagnosis from other periodic fever syndromes is especially important in western European countries. Among these hyper IgD syndrome is common in Netherlands and the tumour necrosis factor receptor-associated periodic syndrome is especially common among Scottish and Irish families. Mutation analysis of the gene may be helpful in diagnosing FMF; however, if this is not possible, a trial of colchicine is a helpful diagnostic tool. The indications for life-long colchicine treatment should be discussed with the family.
CONCLUSION: Familial mediterranean fever and other auto-inflammatory syndromes should be suspected in children with recurrent febrile attacks. Early diagnosis will save the child from unnecessary work-up and kidney involvement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751000     DOI: 10.1007/s00431-003-1223-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

3.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

Authors:  M Centola; G Wood; D M Frucht; J Galon; M Aringer; C Farrell; D W Kingma; M E Horwitz; E Mansfield; S M Holland; J J O'Shea; H F Rosenberg; H L Malech; D L Kastner
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

4.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.

Authors:  H M Hoffman; J L Mueller; D H Broide; A A Wanderer; R D Kolodner
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

5.  Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population.

Authors:  E Yilmaz; S Ozen; B Balci; A Duzova; R Topaloglu; N Besbas; U Saatci; A Bakkaloglu; M Ozguc
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

6.  Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

Authors:  J P Drenth; L Cuisset; G Grateau; C Vasseur; S D van de Velde-Visser; J G de Jong; J S Beckmann; J W van der Meer; M Delpech
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

Review 7.  Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis.

Authors:  D L Gumucio; A Diaz; P Schaner; N Richards; C Babcock; M Schaller; T Cesena
Journal:  Clin Exp Rheumatol       Date:  2002 Jul-Aug       Impact factor: 4.473

8.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

Authors:  C Cazeneuve; H Ajrapetyan; S Papin; F Roudot-Thoraval; D Geneviève; E Mndjoyan; M Papazian; A Sarkisian; A Babloyan; B Boissier; P Duquesnoy; J C Kouyoumdjian; E Girodon-Boulandet; G Grateau; T Sarkisian; S Amselem
Journal:  Am J Hum Genet       Date:  2000-10-03       Impact factor: 11.025

10.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10
View more
  22 in total

1.  Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease.

Authors:  Ismail Simsek; Cem Koz; Nurcan Basar; Ismail Sari; Hakan Erdem; Salih Pay; Bunyamin Kisacik; Muhterem Bahce; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

2.  The phenotype-genotype correlations of FMF patients: a single center study.

Authors:  Onur Sakallioglu; Faysal Gok; Suleyman Kalman; Davut Gul; Erdal Gokcay
Journal:  Rheumatol Int       Date:  2005-09-25       Impact factor: 2.631

3.  Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF.

Authors:  Z Birsin Ozçakar; Fatoş Yalçınkaya; Nilgün Cakar; Banu Acar; A Evren Bilgiç; Nermin Uncu; Nazlı Kara; Mesiha Ekim; Ozgür Kasapçopur
Journal:  Eur J Pediatr       Date:  2011-02-02       Impact factor: 3.183

Review 4.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

5.  The factors considered as trigger for the attacks in patients with familial Mediterranean fever.

Authors:  Omer Karadag; Abdurrahman Tufan; Veli Yazisiz; Kemal Ureten; Sedat Yilmaz; Muhammet Cinar; Ali Akdogan; Hakan Erdem; Mehmet Akif Ozturk; Salih Pay; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 2.631

6.  Renal amyloidosis due to pulmonary tuberculosis in a patient with Down syndrome.

Authors:  Ozan Ozkaya; M Sükrü Paksu; Kenan Bek; Levent Yildiz; Tunç Fişgin; Nevzat Gürmen; Filiz Karagöz
Journal:  Eur J Pediatr       Date:  2005-10-08       Impact factor: 3.183

7.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.

Authors:  Yelda Bilginer; Nuray Aktay Ayaz; Seza Ozen
Journal:  Clin Rheumatol       Date:  2009-09-23       Impact factor: 2.980

8.  MEFV mutations in patients with Familial Mediterranean Fever from the Aegean region of Turkey.

Authors:  Haluk Akin; Huseyin Onay; Emre Turker; Ozgur Cogulu; Ferda Ozkinay
Journal:  Mol Biol Rep       Date:  2009-05-17       Impact factor: 2.316

9.  Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever.

Authors:  Abdullah Uyanik; Fatih Albayrak; M Hamidullah Uyanik; Hakan Dursun; Mustafa Keles; Ramazan Cetinkaya
Journal:  Rheumatol Int       Date:  2009-06-17       Impact factor: 2.631

10.  A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients.

Authors:  Erkan Demirkaya; Yusuf Tunca; Faysal Gok; Seza Ozen; Davut Gul
Journal:  Clin Rheumatol       Date:  2007-11-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.